Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

NCT03724942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Agitation Associated With Dementia of the Alzheimer's Type

Interventions

DRUG: Brexpiprazole

Sponsor

Otsuka Pharmaceutical Co., Ltd.